Microbot Medical Inc. — Director's Dealing 2017

Sep 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2017-09-14

Reporting Person: Gadot Harel (Director, President, CEO and Chairman, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-14	Stock Option (Right to Buy)	$1.05	A	1336522	Acquired	2027-09-14	Common Stock, par value $0.01 per share (1336522)	Direct
2017-09-14	Stock Option (Right to Buy)	$1.05	A	476190	Acquired	2027-09-14	Common Stock, par value $0.01 per share (476190)	Direct

Footnotes

F1: The options vest as follows and in accordance with the terms of the Issuer's Equity Incentive Plan: (a) on the six month anniversary of the date of grant, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

F2: The options vest equally on an annual basis over 60 months commencing on the one year anniversary of the date of grant, and in accordance with the terms of the Issuer's Equity Incentive Plan.